Center for Environmentally
Beneficial Catalysis

  • Home
  • Three McNair Scholars Synthesized Novel Chemicals at CEBC this Summer

Three McNair Scholars Synthesized Novel Chemicals at CEBC this Summer

Thursday, September 24, 2009

Three undergraduates from the McNair Scholars program worked at CEBC this summer.  This federally-funded program helps low income, first generation college students and/or students from underrepresented groups prepare for graduate school.  It is named after the late Ronald E. McNair who perished on the space shuttle Challenger in 1986.

The three Scholars worked with Michael Rubin (second from left), assistant professor of chemistry at the University of Kansas (KU) and researcher with the Center for Environmentally Beneficial Catalysis (CEBC).  The scholars worked with Rubin to build new biologically active drugs that incorporate a triangle-shaped molecule called cyclopropane [link to article].

Two of these students, Joel Lugo Millan (left) and Eric Alicea Ortiz (far right), are from the American University in Puerto Rico.  Their exchange visit to KU this summer was funded by the Kansas NSF-EPSCoR program. The third scholar, Tony Prosser, is from Meridan (second from left) and is a student at KU.

Rubin said that his work with CEBC has “focused on the design and development of new, environmentally benign transition metal-catalyzed processes for manufacturing commodity and specialty chemicals.”

--Story by Claudia Bode

CEBC Calendar

April 12, Wednesday - Mandatory Lab Safety Meeting
All researchers at 1501 Wakarusa Dr. must attend

9:00 a.m. in Building B seminar room

April 24 & 25, Spring IAB/SAB Meeting
Monday, April 24, 11:00 a.m. - 7:30 p.m. at Adams Alumni Center, 1266 Oread Ave.
Tuesday, April 25, 8:00 a.m. - 1:00 p.m. at the CEBC complex, 1501 Wakarusa Drive

April 28, Friday - Shiflett Research Open Laboratory
Tours of facilities & research presentations; light refreshments served
2:00-4:00 p.m., LEEP2 Lab 2444
inquiries: contact


KU Today
48 nationally ranked graduate programs.
—U.S. News & World Report
Pharmacy school No. 2 nationally for NIH funding